Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azzalure and Restylane for Pan-Facial Aesthetic Enhancement
NCT01529203Phase 3Completed
- Sponsor
- Galderma
- Start
- Feb 2012
- Primary completion
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of botulinum toxin type A in rhytides, facial volume loss, sponsored by Galderma. Started Feb 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
rhytidesfacial volume loss
Beyond the preview
Go deeper on NCT01529203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529203.